124 related articles for article (PubMed ID: 35695740)
1. The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing.
Walker EJ; Blanco AM; Carnevale J; Cinar P; Collisson EA; Tempero MA; Ko AH
Pancreas; 2022 Apr; 51(4):302-304. PubMed ID: 35695740
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.
Terraf P; Pareja F; Brown DN; Ceyhan-Birsoy O; Misyura M; Rana S; O'Reilly E; Carlo MI; Aghajanian C; Liu Y; Derakhshan F; Jayakumaran G; Weigelt B; Walsh M; Stadler Z; Offit K; Ladanyi M; Robson M; Zehir A; Reis-Filho JS; Mandelker D
Ann Oncol; 2022 Apr; 33(4):426-433. PubMed ID: 35074424
[TBL] [Abstract][Full Text] [Related]
3. Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.
Walker EJ; Goldberg D; Gordon KM; Pedley C; Carnevale J; Cinar P; Collisson EA; Tempero MA; Ko AH; Blanco AM; Dhawan M
Oncologist; 2021 Nov; 26(11):e1982-e1991. PubMed ID: 34506673
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N
Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863
[TBL] [Abstract][Full Text] [Related]
5. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
[TBL] [Abstract][Full Text] [Related]
6. The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.
Mohindroo C; De Jesus-Acosta A; Yurgelun MB; Maitra A; Mork M; McAllister F
Surg Pathol Clin; 2022 Sep; 15(3):491-502. PubMed ID: 36049831
[TBL] [Abstract][Full Text] [Related]
7. Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.
Berchuck JE; Boiarsky D; Silver R; Sunkara R; McClure HM; Tsai HK; Siegmund S; Tewari AK; Nowak JA; Lindeman NI; Rana HQ; Choudhury AD; Pomerantz MM; Freedman ML; Van Allen EM; Taplin ME
JCO Precis Oncol; 2022 Aug; 6():e2200329. PubMed ID: 36103646
[TBL] [Abstract][Full Text] [Related]
8. Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer.
Lincoln SE; Nussbaum RL; Kurian AW; Nielsen SM; Das K; Michalski S; Yang S; Ngo N; Blanco A; Esplin ED
JAMA Netw Open; 2020 Oct; 3(10):e2019452. PubMed ID: 33026450
[TBL] [Abstract][Full Text] [Related]
9. Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.
Lowery MA; Wong W; Jordan EJ; Lee JW; Kemel Y; Vijai J; Mandelker D; Zehir A; Capanu M; Salo-Mullen E; Arnold AG; Yu KH; Varghese AM; Kelsen DP; Brenner R; Kaufmann E; Ravichandran V; Mukherjee S; Berger MF; Hyman DM; Klimstra DS; Abou-Alfa GK; Tjan C; Covington C; Maynard H; Allen PJ; Askan G; Leach SD; Iacobuzio-Donahue CA; Robson ME; Offit K; Stadler ZK; O'Reilly EM
J Natl Cancer Inst; 2018 Oct; 110(10):1067-1074. PubMed ID: 29506128
[TBL] [Abstract][Full Text] [Related]
10. The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?
Liu YL; Stadler ZK
J Natl Compr Canc Netw; 2021 Jul; 19(7):871-878. PubMed ID: 34340209
[TBL] [Abstract][Full Text] [Related]
11. Genomic testing for pancreatic cancer in clinical practice as real-world evidence.
Hayashi H; Tanishima S; Fujii K; Mori R; Okamura Y; Yanagita E; Matsuoka R; Amano T; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
Pancreatology; 2018 Sep; 18(6):647-654. PubMed ID: 30055942
[TBL] [Abstract][Full Text] [Related]
12. Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
Walker EJ; Carnevale J; Pedley C; Blanco A; Chan S; Collisson EA; Tempero MA; Ko AH
Fam Cancer; 2019 Apr; 18(2):241-251. PubMed ID: 30267352
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer.
Kumari N; Singh RK; Mishra SK; L R; Mohindra S; Krishnani N
Pathol Res Pract; 2021 Jan; 217():153309. PubMed ID: 33341547
[TBL] [Abstract][Full Text] [Related]
14. Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype.
Lowery MA; Jordan EJ; Basturk O; Ptashkin RN; Zehir A; Berger MF; Leach T; Herbst B; Askan G; Maynard H; Glassman D; Covington C; Schultz N; Abou-Alfa GK; Harding JJ; Klimstra DS; Hechtman JF; Hyman DM; Allen PJ; Jarnagin WR; Balachandran VP; Varghese AM; Schattner MA; Yu KH; Saltz LB; Solit DB; Iacobuzio-Donahue CA; Leach SD; O'Reilly EM
Clin Cancer Res; 2017 Oct; 23(20):6094-6100. PubMed ID: 28754816
[No Abstract] [Full Text] [Related]
15. Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors.
Chittenden A; Haraldsdottir S; Chen E; Nissim S
Hematol Oncol Clin North Am; 2022 Oct; 36(5):943-960. PubMed ID: 36265992
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic acinar cell carcinoma is associated with
Kryklyva V; Haj Mohammad N; Morsink FHM; Ligtenberg MJL; Offerhaus GJA; Nagtegaal ID; de Leng WWJ; Brosens LAA
Cancer Biol Ther; 2019; 20(7):949-955. PubMed ID: 31002019
[TBL] [Abstract][Full Text] [Related]
17. Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma.
Yadav S; Kasi PM; Bamlet WR; Ho TP; Polley EC; Hu C; Hart SN; Rabe KG; Boddicker NJ; Gnanaolivu RD; Lee KY; Lindstrom TH; Petersen GM; Couch FJ; McWilliams RR
Clin Cancer Res; 2020 Dec; 26(24):6505-6512. PubMed ID: 33028596
[TBL] [Abstract][Full Text] [Related]
18. Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling.
Kondo T; Yamamoto Y; Fukuyama K; Kanai M; Yamada A; Matsubara J; Quy PN; Yoshioka M; Yamada T; Minamiguchi S; Matsumoto S; Kosugi S; Muto M
Int J Clin Oncol; 2022 Aug; 27(8):1256-1263. PubMed ID: 35567649
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer.
Krepline AN; Geurts JL; George B; Kamgar M; Madhavan S; Erickson BA; Hall WA; Griffin MO; Evans DB; Tsai S; Kim RY
Surgery; 2021 Mar; 169(3):629-635. PubMed ID: 32826069
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a Video-based Remote Germline Testing for Individuals With Pancreatic Ductal Adenocarcinoma.
Kasliwal S; Baydogan S; Harrison D; Mork M; Maitra A; Mcallister F
Gastroenterology; 2022 Jul; 163(1):316-318.e1. PubMed ID: 35339459
[No Abstract] [Full Text] [Related]
[Next] [New Search]
